24 July 2008
Amyotrophic lateral sclerosis after one-year medication of cannabinoid receptor antagonist: A case of iatrogenic ALS?
Marcello ZannaAm J Case Rep 2008; 9:333-337 :: ID: 865124
Abstract
Background: A cannabinoid (CB) receptor antagonist, rimonabant, is a new promising agent in the treatment of atherosclerosis and other disorders including alcoholism. In experiments, CB receptor agonist protects the onset and progression of neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), characterized clinically by progressive devastating systemic muscle weakness and atrophy.
Case Report: A 61-year-old woman taking thyroid hormone and calcium after thyroid resection received rimonabant during 12 months for clinical trial of lipid lowering. During the trial, she developed muscle cramps, and a few months later after the end of rimonabant medication, she developed weakness in the both legs, extending progressively systemic muscle weakness and atrophy. One year later, neurological wouk-up including electromyogram and neuroimagings demonstrated both lower and upper motor neuron sings and a cognitive dysfunction of the frontal lobe, indicating a clinical diagnosis of definite ALS. The patient has gradually worsened to ambulatory diffi culty 15 months after the end of rimonabant medication.
Conclusions: This patient may represent the first case having ALS after medication of CB receptor antagonist. The further follow-up data will address a definitive conclusion.
Keywords: rimonabant, Amiotrofic lateral sclerosis, blood calcium
In Press
12 Feb 2024 : Case report
Diagnostic Challenges and Imaging Considerations for Intraparotid Facial Nerve Schwannoma: A Case Report an...Am J Case Rep In Press; DOI: 10.12659/AJCR.942870
12 Feb 2024 : Case report
Erdheim-Chester Disease Occult on Radiographs and CT but Visible on MRI and PETAm J Case Rep In Press; DOI: 10.12659/AJCR.941169
12 Feb 2024 : Case report
Surgical Treatment of Spontaneous Superficial Temporal Artery Arteriovenous Malformation: A Case ReportAm J Case Rep In Press; DOI: 10.12659/AJCR.942839
13 Feb 2024 : Case report
Warfarin Woes: A Rare Case of Hemoperitoneum with Intramural Small Bowel HematomaAm J Case Rep In Press; DOI: 10.12659/AJCR.943519
Most Viewed Current Articles
10 Jan 2022 : Case report
A Report on the First 7 Sequential Patients Treated Within the C-Reactive Protein Apheresis in COVID (CACOV...DOI :10.12659/AJCR.935263
Am J Case Rep 2022; 23:e935263
19 Jul 2022 : Case report
Atlantoaxial Subluxation Secondary to SARS-CoV-2 Infection: A Rare Orthopedic Complication from COVID-19DOI :10.12659/AJCR.936128
Am J Case Rep 2022; 23:e936128
05 Mar 2022 : Case report
Acute Limb Ischemia After Self-Injection of Crushed Morphine Tablets into the Radial Artery: Role of Infrar...DOI :10.12659/AJCR.935336
Am J Case Rep 2022; 23:e935336
02 Apr 2022 : Case report
Infective Endocarditis Caused by Pseudomonas luteola in a Pediatric Patient. A Case Report and Review of Li...DOI :10.12659/AJCR.935743
Am J Case Rep 2022; 23:e935743